HIVE Blockchain Technologies Ltd. (CVE:HIV) Receives Consensus Rating of “Strong Buy” from Analysts

Shares of HIVE Blockchain Technologies Ltd. (CVE:HIVGet Free Report) have been given a consensus recommendation of “Strong Buy” by the five research firms that are presently covering the company, MarketBeat reports. Five equities research analysts have rated the stock with a strong buy recommendation.

HIV has been the topic of several recent research reports. Roth Capital upgraded HIVE Blockchain Technologies to a “strong-buy” rating in a report on Wednesday, December 18th. Keefe, Bruyette & Woods upgraded HIVE Blockchain Technologies to a “moderate buy” rating in a research note on Wednesday, January 8th. Finally, Rosenblatt Securities raised HIVE Blockchain Technologies to a “strong-buy” rating in a research report on Friday, March 7th.

View Our Latest Stock Analysis on HIV

HIVE Blockchain Technologies Stock Performance

HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.

Further Reading

Analyst Recommendations for HIVE Blockchain Technologies (CVE:HIV)

Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.